Author's Organization:Department of Pharmacognosy, Gifu Pharmaceutical University Department of Pharmacognosy, Gifu Pharmaceutical University Department of Pharmacognosy, Gifu Pharmaceutical University Department of Biological Chemistry, Faculty of Science, Okayama University of Science Department of Biological Chemistry, Faculty of Science, Okayama University of Science Department of Molecular Biology, Institute of Cellular and Molecular Biology, Okayama University Medical School Department of Molecular Biology, Institute of Cellular and Molecular Biology, Okayama University Medical School Meiji Milk Products Co., LTD., Meiji Milk Products Co., LTD.,
Published: February 15, 1997Received: December 09, 1996Available on J-STAGE: March 31, 2008Accepted: January 09, 1997
Advance online publication: -
Revised: -
A xanthone derivative, subelliptenone F, and the related compounds showed an intensive inhibitory effect against topoisomerases I and II in in vitro experiments. These xanthones are prospective lead compounds for anticancer drugs.